{"id":"W4411333669","doi":"10.1002/hon.70093_136","title":"136 | MINIMAL RESIDUAL DISEASE WITH BENDAMUSTINE‐RITUXIMAB WITH OR WITHOUT ACALABRUTINIB IN PATIENTS WITH PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA: RESULTS FROM THE ECHO TRIAL","year":2025,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"AstraZeneca","keywords":"Bendamustine; Mantle cell lymphoma; Rituximab; Medicine; Minimal residual disease; Oncology; Internal medicine; Lymphoma; Cancer research; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002262531,0.0005229219,0.001604027,0.0001620628,0.0001621444,0.001122681,0.0004138655,0.0007093239,0.002487056],"category_scores_gemma":[0.001336669,0.0002269953,0.001900351,0.0002788523,0.0004766234,0.0008037331,0.0003077627,0.001678709,0.0005898634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005027199,"about_ca_system_score_gemma":0.0004953482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003458508,"about_ca_topic_score_gemma":0.001176163,"domain_scores_codex":[0.999272,0.0003763086,0.00007619493,0.0001235667,0.0000688314,0.00008297253],"domain_scores_gemma":[0.9993945,0.0001936684,0.0001561298,0.00005853325,0.0000399562,0.0001571066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8834454,0.005363128,0.01268265,0.001664657,0.004723572,0.0001383734,0.0001277428,0.0008569331,0.008873861,0.0002601969,0.003591208,0.07827225],"study_design_scores_gemma":[0.7111095,0.2095154,0.06281956,0.0002322454,0.004866463,0.000391725,0.00008079994,0.0009227057,0.001567619,0.000580419,0.007853612,0.00005999401],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827883,0.01221139,0.0002594539,0.0007784806,0.0002424989,0.0003694128,0.001244465,0.00004158689,0.00206448],"genre_scores_gemma":[0.9916248,0.002877577,0.0003384303,0.0009176339,0.0003929165,0.000386812,0.002426873,0.00001556807,0.001019443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002487056,"threshold_uncertainty_score":0.01196557,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02236552243145124,"score_gpt":0.3106704017626135,"score_spread":0.2883048793311622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}